Pancreatic cancers consist of a heterogeneous amalgam of assorted cell types, making it challenging to develop a classification system that groups these tumors according to common molecular features. A new study tackles this important issue using bioinformatics approaches to decipher gene expression signatures derived specifically from either tumor cells or nonmalignant stromal cells that predict patient outcome and may inform personalized treatments.
References
Sotiriou, C. & Pusztai, L. N. Engl. J. Med. 360, 790–800 (2009).
Meyer, S.C. & Levine, R.L. Lancet Oncol. 15, e382–e394 (2014).
Ryan, D.P., Hong, T.S. & Bardeesy, N. N. Engl. J. Med. 371, 1039–1049 (2014).
Feig, C. et al. Clin. Cancer Res. 18, 4266–4276 (2012).
Moffitt, R.A. et al. Nat. Genet. 47, 1168–1178 (2015).
Stephen, A.G., Esposito, D., Bagni, R.K. & McCormick, F. Cancer Cell 25, 272–281 (2014).
Chen, J.C. et al. Cell 159, 402–414 (2014).
Suvà, M.L. et al. Cell 157, 580–594 (2014).
Lee, J.J. et al. Proc. Natl. Acad. Sci. USA 111, E3091–E3100 (2014).
Rhim, A.D. et al. Cancer Cell 25, 735–747 (2014).
Sherman, M.H. et al. Cell 159, 80–93 (2014).
Campbell, P.J. et al. Nature 467, 1109–1113 (2010).
Yachida, S. et al. Nature 467, 1114–1117 (2010).
Waddell, N. et al. Nature 518, 495–501 (2015).
Provenzano, P.P. et al. Cancer Cell 21, 418–429 (2012).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Kottakis, F., Bardeesy, N. Gene signatures from pancreatic cancer tumor and stromal cells predict disease outcome. Nat Genet 47, 1102–1103 (2015). https://doi.org/10.1038/ng.3408
Published:
Issue Date:
DOI: https://doi.org/10.1038/ng.3408
- Springer Nature America, Inc.
This article is cited by
-
Pancreatic cancer
Nature Reviews Disease Primers (2016)